How the rise of weight-loss drugs could reshape food markets in the Global South

AI Summary

A recent article discusses the rise of GLP-1 weight-loss drugs in wealthy countries and the potential unintended effects this trend could have on food markets and environments in low- and middle-income countries, highlighting shifts in global health and nutrition dynamics.

A new article published in Globalization and Health warns that the rapid rise of GLP-1 weight-loss drugs in high-income countries could have unintended consequences for food environments in low- and middle-income countries.